Oslo - 12. February 2016 - Serodus ASA (Oslo Axess, SER) will present the Q4 results 2015 at Hotel Continental, Stortingsgaten 24/26, Oslo, Wednesday 17 February 2016 at 08:00. The presentation will be held by CEO Eva Steiness and CFO Tore Kvam.

The presentation will be webcated at www.serodus.com after the completion of the live presentation.

For more information contact:

Tore Kvam

CFO, Serodus ASA

Mobile: +47 959 34 199

e-mail: tore.kvam@serodus.com

Serodus ASA is a Norwegian drug development company, focusing on new therapeutic products for the treatment of cardiovascular and metabolic diseases with large unmet clinical needs. The company's business model is to seek partnering with international pharmaceutical companies after having demonstrated clinical effect in humans. For more information see www.serodus.com.

Serodus ASA issued this content on 12 February 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 February 2016 08:44:25 UTC

Original Document: http://www.serodus.com/News/2016/Invitation-to-a-presentation-of-Q4-2015-results